Plasma interferon-γ, interleukin-10 and soluble markers of immune activation in infants with primary adenovirus (ADV) and respiratory syncytial virus (RSV) infection

European Cytokine Network

Volumn 16, Issue 1, 2005, Pages 35-40

  Fernández, J Alonso ^a   Tapia, Lorena ^a   Palomino, M Angélica ^a   Larrañaga, Carmen ^a   Peña, Mónica ^a   Jaramillo, Héctor ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Adenovirus; IFN ; IL 10; Respiratory syncytial virus; SCD25; STNFR II

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADENOVIRUS; ARTICLE; ASTHMA; BLOOD LEVEL; BRONCHIECTASIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; PRIMARY IMMUNE RESPONSE; PROGNOSIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; STATISTICAL ANALYSIS; WHEEZING;

ACUTE DISEASE; ADENOVIRIDAE INFECTIONS; BIOLOGICAL MARKERS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERFERON TYPE II; INTERLEUKIN-10; MALE; RECEPTORS, INTERLEUKIN-2; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY TRACT INFECTIONS; SOLUBILITY;

EID: 16444387028     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999; 282: 1440.
2. Avendano LF, Palomino MA, Larrañaga C. Surveillance for respiratory syncytial virus in infants hospitalized for acute lower respiratory infection in Chile (1989 to 2000). J Clin Microbiol 2003; 41: 4879.
3. Palomino MA, Larranaga C, Villagra E, Camacho J, Avendano LF. Adenovirus and respiratory syncytial virus-adenovirus mixed acute lower respiratory infections in Chilean infants. Pediatr Infect Dis J 2004; 23: 337.
4. Kawasaki Y, Hosoya M, Katayose M, Suzuki H. Correlation between serum interleukin 6 and C-reactive protein concentrations in patients with adenoviral respiratory infection. Pediatr Infect Dis J 2002; 21: 370.
5. Chuang YY, Chiu CH, Wong KS, et al. Severe adenovirus infection in children. J Microbiol Immunol Infect 2003; 36: 37.
6. Mistchenko AS, Diez RA, Mariani AL, et al. Cytokines in adenoviral disease in children: association of interleukin-6, interleukin-8, and tumor necrosis factor alpha levels with clinical outcome. J Pediatr 1994; 124: 714.
7. Spigelblatt L, Rosenfeld R. Hyperlucent lung: long term complication of adenovirus type 7 pneumonia. Can Med Assoc J 1983; 128: 47.
8. Simila S, Linna O, Lanning P, Heihhinen E, Ala-Houhala M. Chronic lung damage caused by adenovirus type 7: a ten-year follow-up study. Chest 1981; 80: 127.
9. Cherri JD. Adenoviruses. In: Feigin. Cherry, eds. Textbook of Pediatrics Infectious Diseases. 4th. Ed. Philadelphia: W.B. Saunders Company, 1998: 1666; Vol. 2.
10. McNamara PS, Smyth RL. The pathogenesis of respiratory syncytial virus disease in childhood. Br Med Bull 2002; 61: 13.
11. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years, Lancet 1999; 354: 541.
12. Sigurs N, Bjarnason R, Sigurbergson F, Kjellman B. Respiratory syncytial virus brochiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000; 161: 1501.
13. O'Garra A, Murphy K. Role of cytokines in determining T lymphocyte function. Curr Opin Immunol 1994; 6: 458.
14. Openshaw P, Murphy EE, Hosken NA, et al. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J Exp Med 1995; 182: 1357.
15. Cobbold S, Waldmann H. Infectious tolerance. Cur Opin Immunol 1998; 10: 518.
16. Mills KHG, McGuirk P Antigen-specific regulatory T cells - their induction and role in infection. Semin Immunol 2004; 16: 107.
17. Diaz PV, Calhoun WJ, Hinton KL, et al. Differential effects of respiratory syncytial virus and adenovirus on mononuclear cell cytokine responses. Am J Respir Crit Care Med 1999; 160: 1157.
18. Aberle JH, Aberle SW, Rebhandl W, Pracher E, Kundi M, Popow-Kraupp T. Decreased interferon-gamma response in respiratory syncytial virus compared to other respiratory viral infections in infants. Clin Exp Immunol 2004; 137: 146.
19. Green S, Vaughn DW, Kalayanarooj S, et al. Early Immune Activation in Acute Dengue Illness Is Related to Development of Plasma Leakage and Disease Severity. J Infect Dis 1999; 179: 755.
20. Sawayama Y, Hayashi J, Kawakami Y, et al. Serum soluble interleukin-2 receptor levels before and during interferon treatment in patients with chronic hepatitis B virus infection. Dig Dis Sci 1999; 44: 163.
21. Dai H, Guzman J, Bauer PC, Costabel U. Elevated levels of soluble TNF receptors in bronchoalveolar lavage fluid in extrinsic allergic alveolitis. Clin Exp Allergy 1999; 29: 1209.
22. Pforte A, Brunner A, Gais P, et al. Increased levels of soluble serum interleukin-2 receptor in extrinsic allergic alveolitis correlate with interleukin-2 receptor expression on alveolar macrophages. J Allergy Clin Immunol 1994; 94: 1057.
23. Hoeger PH, Niggemann B, Ganschow R, Dammann C, Haeuser G. Serum levels of sCD23 and sCD25 in children with asthma and in healthy controls. Allergy 1994; 49: 217.
24. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-γ: an overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75: 163.
25. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998; 8: 275.
26. O'Garra A, Arai N. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol 2000; 10: 542.
27. Tripp RA, Moore D, Barskey 4th A, et al. Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA. J Infect Dis 2002; 185: 1388.
28. Brandenburg AH, Kleinjan A, van Het Land B, et al. Type 1-like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity. J Med Virol 2000; 62: 267.
29. Tripp RA. Moore D, Jones L, Sullender W, Winter J, Anderson LJ. Respiratory syncytial virus G and/or SH protein alters ThI cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice. J Virol 1999; 73: 7099.
30. Lambrecht BN, Hammad H. Taking our breath away: dendritic cells in the pathogenesis of asthma. Nat Rev Immunol 2003; 3: 994.
31. Roman M, Calhoun WJ, Hinton KL. et al. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med 1997; 156: 190.
32. Renzi PM, Turgeon JP, Marcotte JE, et al. Reduced IFN-γ production in infants with bronchiolitis and asthma. Am J Respir Crit Care Med 1999; 159: 1417.
33. Bom L, Heijnen CJ, Kavelaars A, et al. Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study. Am J Respir Crit Care Med 2000; 161: 1518.
34. Smyth RL, Fletcher JN, Thomas HM, Hart CA. Immunological responses to respiratory syncytial virus infection in infancy. Arch Dis Child 1997; 76: 210.
35. Rubin LA, Kurman CC, Fritz ME, et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985; 135: 3172.
36. Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 1990; 87: 3127.
37. Santee SM, Owen-Schaub LB. Human tumor necrosis factor receptor p75/80 (CD 12Ob) gene structure and promoter characterization. J Biol Chem 1996; 271: 21151.
38. Agostini C, Zambello R, Sancetta R, et al. Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease. Am J Respir Crit Care Med 1996; 153: 1359.
39. Ware CF, Crowe PD, Vanarsdale TL, et al. Tumor necrosis factor (TNF) receptor expression in T lymphocytes: Differential regulation of the type I TNF receptor during activation of resting and effector T cells. J Immunol 1991; 147: 4229.
40. Gehr G, Gentz R, Brockhaus M, Loetscher H, Lesslauer W. Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation. J Immunol 1992; 149: 911.
41. Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2003; 168: 633.
42. Camara AA, Silva JM, Ferriani VP, et al. Risk factors for wheezing in a subtropical environment: role of respiratory viruses and allergen sensitization. J Allergy Clin Immunol 2004; 113: 551.
43. Openshaw PJ, Hewitt C. Protective and harmful effects of viral infections in childhood on wheezing disorders and asthma. Am J Respir Crit Care Med 2000; 162: S40.